Toggle Nav
My Cart
Search
Advanced Search
  • Compare Products
Menu
Account
Settings

Vital Signs The Analyst's Perspective - April 2016 Issue

Vital Signs The Analyst's Perspective - April 2016 Issue

RELEASE DATE
24-May-2016
REGION
Global
Research Code: 9A35-00-4B-00-00
SKU: HC02640-GL-MR_18576

$450.00

Special Price $337.50 save 25 %

In stock
SKU
HC02640-GL-MR_18576

$450.00

$337.50 save 25 %

DownloadLink
Add to Compare

Pay by invoice

ENQUIRE NOW

Description

This Vital Signs issues trends in orphan drugs, genetic research apps, Thermo Fisher Scientific's acquisition of Affymetrix, and the Zika Virus.

Table of Contents

April 2016 Issue

Request Sample
Related Research

Global RNA Therapeutics Growth Opportunities

Growth Opportunities for Commercial AI in Medical Imaging

Global Interventional X-ray (IXR) Growth Opportunities

GROWTH OPPORTUNITIES IN SUPPLY CHAIN MONITORING, VACCINE DEVELOPMENT, COVID DIAGNOSIS, AND WIRELESS CHARGED WEARABLE DEVICES

Global NGS Library Preparation Growth Opportunities

US Internet of Medical Things (IoMT) and Remote Patient Monitoring Growth Opportunities

Growth Opportunities for Digital Twins in Global Healthcare

INNOVATIONS AND GROWTH OPPORTUNITIES IN NOVEL DIAGNOSTICS, MONITORING TECHNOLOGIES AND ADVANCED MEDICAL DEVICES

US Health Insurance Growth Opportunities

Pediatric Imaging Technology Innovation and Growth Opportunities

Popular Topics

3d printer market share

commercial uav market

fleet management market

smart home market

neurology market

residential solar market

fragrance market

polyamides market

alternative energy market

flexible packaging market

This Vital Signs issues trends in orphan drugs, genetic research apps, Thermo Fisher Scientific's acquisition of Affymetrix, and the Zika Virus.
More Information
No Index No
Podcast No
Author Christi Bird
Industries Healthcare
WIP Number 9A35-00-4B-00-00
Is Prebook No